Author:
Velingkar V.S.,Chindhe A.K.,Sanaye Mrunal,Gatane Madhumangiri
Abstract
Background:
3-(1, 4-diazepanyl)-methyl-phenyl-sulphonamides were prepared by reacting 3-nitrobenzaldehyde with substituted 1, 4-diazepanes which were reduced to obtain intermediate amines. Reaction of these amines with substituted sulfonyl chlorides using TEA in DCM followed by KOH in methanol afforded compounds which under HCl salt formation with IPA.HCl gave title compounds with good yields.
Objective:
To synthesize and evaluate 3-(1, 4-diazepanyl)-methyl-phenyl-sulphonamides as 5-HT6 Antagonists in Cognitive Disorders.
Method:
Melting points were determined in open capillary tube and are found uncorrected. The completion of organic reactions and purity of the compounds were checked by TLC on pre-coated Silica gel aluminum plates using a mixture of chloroform and methanol (8:2, v/v) as an eluent. UV light or iodine vapour was used for visualization. Infrared (IR) spectra were recorded (in KBr) on a Fourier-transform IR, model IR Affinity-1 (SHIMADZU), and the values are expressed in cm-1. The 1H NMR spectra were obtained on multinuclear FT NMR Spectrometer, model Advance-II (Bruker), (400 MHz) using CDCl3 as solvent, Tetramethylsilane (TMS) as an internal standard. The chemical shift values are expressed as ppm (parts per million) units, downfield from TMS.
Results:
Experimental results of synthesized derivatives were shown comparable activity to the earlier reported derivatives in literature on 5-HT6 antagonist therapeutic area.
Conclusion:
It can be concluded that test compounds have an ability to prevent loss of memory.
Publisher
Bentham Science Publishers Ltd.
Reference31 articles.
1. Hoyer D, Clarke DE, Fozard JR, et al.
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Pharmacol Rev
1994;
46
(2)
: 157-203.
2. Glennon RA.
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
J Med Chem
2003;
46
(14)
: 2795-812.
3. Sebben M, Ansanay H, Bockaert J, Dumuis A.
5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture.
Neuroreport
1994;
5
(18)
: 2553-7.
4. Holenz J, Pauwels PJ, Díaz JL, Mercè R, Codony X, Buschmann H.
Medicinal chemistry strategies to 5-HT(6) receptor ligands as potential cognitive enhancers and antiobesity agents.
Drug Discov Today
2006;
11
(7-8)
: 283-99.
5. Davies S, Silvestre J, Guitart X.
Drug discovery targets: 5-HT6 receptor.
Drugs Future
2005;
30
(5)
: 479-95.